Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VHCIX vs. XLV: which is better?

Bottom line

VHCIX vs XLV: the short answer

VHCIX (Vanguard Health Care Index Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

But VHCIX is far broader, holding 407 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 0.09% — a difference of $1.00 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +7.2% for VHCIX (reporting dates differ).

Updated Nov 19, 2026

VHCIX vs XLV side by side

VHCIXXLV
TypeMutual fundETF
Fund familyVanguardSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.09%0.08%
Annual cost per $10k$9$8
10-yr cost on $10k (prospectus)$115$103
Max front load0%None
12b-1 fee0%0.02%
1-yr return+2.7%+14.5%
5-yr return (annualized)+7.2%+8.1%
10-yr return (annualized)+8.8%+9.8%
Best quarter+16.5%+14.5%
Worst quarter−13.1%−12.7%
Net assets (fund)$19.0B$40.6B
Number of holdings40765
Portfolio turnover4%2%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearVHCIXXLVDifference
2024+2.7%+2.5%+0.1%
2023+2.5%+2.0%+0.5%
2022−5.5%−2.1%−3.5%
2021+20.5%+25.9%−5.4%
2020+18.2%+13.3%+5.0%
2019+22.0%+20.7%+1.3%
2018+5.6%+6.3%−0.7%
2017+23.4%+21.7%+1.7%
2016−3.3%−2.8%−0.5%

Source: Fund prospectus bar charts

Holdings overlap

23 of VHCIX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingVHCIXXLV
Eli Lilly & Co14.04%16.51%
Johnson & Johnson8.47%10.64%
AbbVie Inc6.09%7.74%
UnitedHealth Group Inc5.45%6.57%
Merck & Co Inc4.66%5.52%
Thermo Fisher Scientific Inc2.93%3.24%
Amgen Inc2.87%3.40%
Gilead Sciences Inc2.64%2.73%
Intuitive Surgical Inc2.38%2.45%
Pfizer Inc2.35%2.39%
Abbott Laboratories2.35%2.75%
Bristol-Myers Squibb Co1.84%2.05%
Danaher Corp1.84%2.09%
CVS Health Corp1.83%2.30%
Vertex Pharmaceuticals Inc1.80%2.19%

Source: SEC Form N-PORT

VHCIX top 10

  1. Eli Lilly & Co — 14.04%
  2. Johnson & Johnson — 8.47%
  3. AbbVie Inc — 6.09%
  4. UnitedHealth Group Inc — 5.45%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 2.93%
  7. Amgen Inc — 2.87%
  8. Gilead Sciences Inc — 2.64%
  9. Intuitive Surgical Inc — 2.38%
  10. Pfizer Inc — 2.35%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between VHCIX and XLV?
VHCIX (Vanguard Health Care Index Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. But VHCIX is far broader, holding 407 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, VHCIX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both VHCIX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.